CareCloud stock (US14169G1058): turnaround hopes meet harsh reality after Nasdaq delisting and Q1 loss

CareCloud has been delisted from Nasdaq and reported a sharp year?over?year revenue drop and net loss for Q1 2025. The health IT provider is trying to stabilize its business under heavy pressure from debt and competition.

CareCloud stock has had a turbulent start to 2025: the health IT provider reported significantly lower revenue and a net loss for the first quarter and has since been delisted from Nasdaq and moved to OTC trading, according to a quarterly update published on May 13, 2025 and subsequent filings reported by GlobeNewswire as of 05/13/2025 and exchange notices summarized by MarketBeat as of 05/16/2026.

As of: 17.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: MTBC
• Sector/industry: Healthcare IT, medical information systems
• Headquarters/country: Somerset, New Jersey, USA
• Core markets: US outpatient practices, ambulatory care, physician groups
• Key revenue drivers: Revenue cycle management services, cloud-based EHR and practice management software, related IT services
• Home exchange/listing venue: OTC market (formerly Nasdaq, ticker CCLD)
• Trading currency: USD

CareCloud: core business model

CareCloud focuses on digital solutions for medical practices and healthcare providers in the United States. The company offers a mix of software and services aimed at helping physicians handle patient records, billing, and administrative workflows in a highly regulated environment. Its roots lie in revenue cycle management, where it takes over billing and claims processes for clients.

Over time, CareCloud has expanded into a broader healthcare IT platform. It markets cloud-based electronic health record systems, practice management tools, patient engagement modules, and analytics. By bundling software with outsourced back-office services, the company aims to become a one-stop partner for small and midsize practices that lack in-house IT and billing expertise.

This model typically generates recurring revenue through subscription fees for software and percentage-based fees on collected claims for revenue cycle management. The strategy is to deepen relationships with existing practices while acquiring new ones, often by demonstrating improved collections, reduced denials, and better productivity compared with manual or fragmented solutions.

Main revenue and product drivers for CareCloud

The most important revenue drivers for CareCloud include its revenue cycle management contracts, where the company processes medical billing, manages insurance claims, and follows up on receivables for clients. These services are closely tied to volumes of patient visits, payer mix, and reimbursement trends across the US healthcare system, which makes them sensitive to macroeconomic and regulatory change.

Alongside services, CareCloud’s cloud-based software platforms are central to its offering. Electronic health records, practice management, and scheduling modules are designed to support day-to-day operations in medical practices. Add-on products such as patient portals, telehealth modules, and analytics dashboards expand the addressable wallet share per customer and can help increase switching costs.

Another important driver is the company’s ability to cross-sell services to existing customers obtained through past acquisitions. Over the last decade, CareCloud has integrated several acquired platforms and client bases, attempting to migrate them onto a more unified technology stack. Execution in this area remains crucial: successful migrations and cross-selling can support margins, whereas integration setbacks or client churn can weigh on growth and profitability.

Recent financial performance and Nasdaq delisting

For the first quarter of 2025, CareCloud reported revenue of approximately USD 26 million, down markedly from the prior-year quarter, and posted a net loss, reflecting operational challenges and restructuring effects, according to the earnings release dated May 13, 2025 published via GlobeNewswire as of 05/13/2025. The company highlighted efforts to reduce costs and streamline its operations in response to market pressures.

In parallel with these weaker results, the company faced compliance issues related to Nasdaq listing requirements. After a prolonged period of trading below minimum bid price thresholds and market capitalization levels, CareCloud was ultimately delisted from Nasdaq and moved to trading on the over-the-counter market, as reflected in exchange communications and summarized by financial data platforms such as MarketBeat as of 05/16/2026. This shift typically reduces liquidity and may limit access to some institutional investors.

The combination of lower revenue, ongoing net losses, and the step down from a major exchange underscores the pressure the company is under. Management has been working on restructuring initiatives, including cost cuts and portfolio optimization, to stabilize the financial position. However, such measures can take time to translate into sustained profitability, particularly in a competitive market with rapidly evolving technology requirements.

Industry trends and competitive position

CareCloud operates in the broader US healthcare IT market, where providers are upgrading systems to meet regulatory requirements, enable value-based care models, and respond to patient expectations for digital access. Demand for integrated solutions that link clinical documentation, billing, and patient engagement tools has been robust, driven by digitization and pressure to improve efficiency.

At the same time, competition is intense. CareCloud faces rivals ranging from large, established vendors serving hospital systems to more focused cloud-native platforms aimed at small practices. Many competitors have greater scale, stronger balance sheets, or deeper integration with large health systems, which can influence pricing power, product roadmaps, and customer acquisition costs.

For a smaller player like CareCloud, differentiation often depends on niche strengths, such as serving specific specialties, offering flexible service bundles, or delivering high-touch support for independent practices. The company’s ability to innovate in areas like automation of billing workflows, AI-assisted coding, and interoperability with other systems will be key for sustaining its position in the crowded US market.

Why CareCloud matters for US investors

For US-based investors, CareCloud represents exposure to the digitization of healthcare administration and the ongoing shift toward cloud-based solutions in outpatient care. Even though the stock now trades over the counter instead of on Nasdaq, the company remains part of the US healthcare IT ecosystem that underpins many physician practices and clinics across the country.

Developments at CareCloud can shed light on broader themes, including how smaller technology vendors cope with reimbursement volatility, regulatory change, and rising cybersecurity demands. Their experience may illustrate the challenges of achieving scale and consistent profitability in a market dominated by large electronic health record platforms and diversified health IT firms.

For portfolio strategies centered on health technology, smaller names like CareCloud can serve as case studies on execution risk, capital structure constraints, and the impact of exchange listing status on investor access and liquidity. US investors monitoring the sector often watch such companies to gauge consolidation trends, pricing dynamics, and the appetite of larger players for potential acquisitions.

What type of investor might look at CareCloud – and who should be cautious?

Given its shift to OTC trading, reduced market capitalization, and history of net losses, CareCloud will tend to attract investors with a tolerance for elevated volatility and company-specific risk. Such investors might focus on potential turnaround scenarios, restructuring progress, and any signs of stabilization in revenue and margins over coming quarters.

More risk-averse investors, particularly those requiring high liquidity and stable earnings histories, are likely to be cautious. Over-the-counter trading often implies wider bid-ask spreads and lower daily volume compared with major exchanges, which can complicate larger transactions and increase trading costs.

The company’s future trajectory will depend on its ability to manage debt, retain and grow its customer base, and invest appropriately in product development without overextending its balance sheet. For investors prioritizing steady dividend income or blue chip characteristics, these factors may not align with typical selection criteria.

Conclusion

CareCloud stands at a sensitive point in its corporate development. The combination of weaker first-quarter 2025 results, continuing net losses, and a delisting from Nasdaq underscores the pressure on its business model and balance sheet. At the same time, the company addresses real needs in US healthcare, offering billing and IT services that many independent practices rely on to function effectively.

Outcomes for shareholders will depend on whether management can execute restructuring plans, stabilize revenue, and navigate the liquidity and perception challenges associated with OTC trading. In a competitive industry where scale and capital access matter, progress may be uneven and subject to external factors such as reimbursement trends and regulatory change. For now, CareCloud remains a small but instructive player in the larger story of healthcare digitization in the United States.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.